WeGovy Use Up Amongst Teens

Wegovy Use is Rising Among U.S. Teens as the Obesity Crisis Worsens.

According to Data Shared With Reuters, More Teens Are Increasingly Turning to the Weight-loss Drug.

It Comes as Families and Their Doctors Gain Confidence in Its Use for Younger Demographics.

Data Found that the Average Rate of Teens Beginning Treatment With the Highly Effective Novo Nordisk Drug Grew 50% Last Year to 14.8 Prescriptions Per 100,000 Adolescents.

Wegovy Became an Option to Treat Adolescents in Late 2022 After Decades in Which the Conventional Approaches of Diet, Exercise and Counseling Largely Failed.

However, Some Doctors Are Hesitant Because the Drugs' Long-term Safety for Children During a Critical Phase of Development is Unknown, and the Treatments May Need to Be Used Indefinitely.

Medical Professionals Say It is Important to Continue to Monitor and Better Understand Outcomes From the Medications Both Positive and Negative Before Widespread Use.